QuADRANT Second Workshop Day 1 Slides
Webinar 1, 13th Jan 2022
Session 1.2: Clinical Audit – Setting the Scene
OVERVIEW OF PROJECT AIMS AND STRUCTURE: CONTEXT, BACKGROUND & DEFINITIONS IN USE
David Howlett (Project Leader, Chair of the ESR Audit and Standards Subcommittee and former-chair of the UK Royal College of Radiologists (RCR) Clinical Audit and Quality Improvement Committee)
PREVIOUS KEY WORK, OVERVIEW OF CLINICAL AUDIT RELATED INITIATIVES, CLINICAL AUDIT AND THE BACKGROUND TO THE BSSD
Steve Ebdon-Jackson (Health Policy Maker / Health Economist)
SUMMARY OF FIRST QUADRANT WORKSHOP
Wolfgang Wadsak (Radiopharmacist)
Session 1.3: Status of Clinical Audit in the EU 27+4 – WP3 (Part 1)
OVERVIEW OF QUADRANT WORK PACKAGE 3 – MAIN SURVEY, EXPERT INTERVIEWS, LITERATURE REVIEW
Primoz Strojan (Institute of Oncology Ljubljana, Slovenia)
CLINICAL AUDIT PRACTICE AND PROCESS
Diana Paez (Section Head, Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency)
PATIENT INVOLVEMENT
Erik Briers (ESR-Patients‘ Advisory Group (ESR-PAG))
Q&A SESSION: FROM LABELIX TO A PROPOSAL FOR CREATION OF A NEW CEN TECHNICAL COMMITTEE
Jean-Charles Leclerc (Chair of the labeling committee, Labelix, France)
Session 1.4: Clinical Audit, Regulatory Control and the BSSD
REGULATORY CONTROL – CLINICAL AUDIT AND THE BSSD (KEY OUTCOMES FROM WP3)
Alexandra Karoussou-Schreiner (Chair of HERCA Working Group – Medical Applications, Medical Physics Expert, Luxembourg Ministry of Health)